{"ticker": {"uuid": "40923911-ab53-450e-bed7-ae2397d54d10", "symbol": "1J5", "name": "Hyphens Pharma International Limited", "exchange": "SES", "country": "SG", "sector": "Healthcare", "industry": "Medical Distribution"}, "articles": [{"title": "kopi-C with CEO of Hyphens Pharma International: From dispensary to ASEAN's dermatology specialist", "summary": "", "url": "https://news.google.com/rss/articles/CBMiWEFVX3lxTFBySWptZVlGeWdJT3Z0ZXVYOTJ2V3R4M1NXVTRGS3IwdG9rWDNTRW9kcTZfbkxRR1dfMHRVZmVxY2V3Qmo1SzlWMmlMc0VQaHBSSERkRWNiVEQ?oc=5", "source_name": "Beansprout", "published_at": "2026-06-16T07:00:00+00:00", "published_display": "16 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Hyphens Pharma grants Swiss pharma company rights to commercialise Cerapro MED Skin Barrier Cream", "summary": "", "url": "https://news.google.com/rss/articles/CBMiiwFBVV95cUxQQVFlYi1TZjNiYXM1RVNXZVE4bHNKMGlzd240eFBpVE1QaDBxVDR3Y1JCbW50YzI2TkZBNUNoc0h4emk1LUoyckhBMmV6blpnTmQ3bFpSMzJDVHJFU1pXYWJTekEwc2xPeV9GSHRJRkhCT0RBR29mdDFCQVdmRzNTV18tVElsZEZRQkFz?oc=5", "source_name": "Market source", "published_at": "2026-01-04T08:00:00+00:00", "published_display": "04 Jan 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Hyphens Pharma earnings down 66.3% y-o-y for 1HFY2025 to $1.9 mil", "summary": "", "url": "https://news.google.com/rss/articles/CBMihwFBVV95cUxQRnIxbXN0TzBRMHE2WmhQWS1jSzNrVW1MVWYzOW80SnBNSVR2Qno0VFhSdF9FLVdFWVowQWs0T1FrTlBEaS1EZTM1SG1mRXlZUndGUFBqODJVcjFNaTE5VExodjZ0OXItV1FoaEFyUUpSdHRNa0ZXcFBWbUJqWWx2R1M3anA1RWs?oc=5", "source_name": "Market source", "published_at": "2025-08-12T07:00:00+00:00", "published_display": "12 Aug 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Ardence Pharma deal favourable, analysts keep 'buy' on Hyphens Pharma", "summary": "", "url": "https://news.google.com/rss/articles/CBMiugFBVV95cUxQSE9YV094ejlnQXZ5dnc0T3FyVmkzc0JxckZOdkxOLUlNamJvbXducEd5Z19HYzV3c2RJcnBId1FqV0RRZ2tXWW1NNTZMQjR6R2tRVS0tZG9TVWFFRXVTa0tzdDJab2tKcFkwOXVLRGFkTHdYWWVCS3hBWks0aGxLNHpkck5XSnhJdjZ2YVRta3M4Uk1mSms4WFdwa0tZU2NROVFhd1dpY01WdFFoVVNfNW95TU5YcVd1WlE?oc=5", "source_name": "The Edge Singapore", "published_at": "2023-10-23T07:00:00+00:00", "published_display": "23 Oct 2023 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Hyphens Pharma to acquire remaining 58% of shares in Ardence Pharma, making it a wholly-owned subsidiary", "summary": "", "url": "https://news.google.com/rss/articles/CBMiywFBVV95cUxPejB1T1RRdDhWZUxuT3NqbWtQT3BUM0h5WHFfSUQ3WlV6T3ZMQWdpZ1MxWmtxRWcxTUlWQXZ0YkFweWFHQkFIb0t4TjV5amJORmdiYm55NE95azU2THZBVkt5SVZURDkzTHA2Y2VuQklfMFhfME5CR3RvNWtGWFdpaVJ1NWhiOXhyTTV1MDlKWU9na3ZIdFlETlA1SFoxbEtPNzNiaWF4Um9QdWNzQ0NsTkN4UUtMOXk2WHdOYmdCZ3JtNy1GTm5zeF8zWQ?oc=5", "source_name": "The Edge Singapore", "published_at": "2023-10-17T07:00:00+00:00", "published_display": "17 Oct 2023 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "6 Things Investors should know about Hyphens Pharma (SGX: 1J5)", "summary": "", "url": "https://news.google.com/rss/articles/CBMikwFBVV95cUxPSXJtZDBRQ2FnWFRSWHRHUHRDMXhaTEVweWhmRm5BRkVaeDRJWEJhMFFWN2NTdTFhNnU2SXh4cjZQejcySGstWmZDTW90TzRKaUNtZ0VPUVAwQTUxd3U2T1BpVURHSTJlS3UtZk02N3RSRW1tMml5djNFcTB2R29zVTY0TmZJem5tN2NtN0ZPR3RMYmM?oc=5", "source_name": "SmallCapAsia", "published_at": "2022-06-29T07:00:00+00:00", "published_display": "29 Jun 2022 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Hyphens Pharma inks exclusive licensing deal with Favorex to commercialise biosimilar in Singapore, Malaysia, Philippines", "summary": "", "url": "https://news.google.com/rss/articles/CBMi_wFBVV95cUxQd2ZoVEpLUm9hN3BEZUZTekJIWGNxRThjYWxBbmE2ZU44bW40UGc0Ml9FOC1CRVZpVkx1c0tsVDdnU3dPVVk0TGRPeURZLVFuekh6U3lfNk5XSzUwRFJhUTFHSm1BM0dUUXp0NlJMaU5aM0RFNXUzbHl1b0p4T0J6RE1HelBHSHc4bHpQdnpyWVlKdnZVNnNkWFg1UzQzRXIxbTRmUjNYRVoyc0dEVGdHU2dXODNWN0ZCZ3JuX0FBUnRzR3dXNDJNc3VKSzJyWi03T2x6dzZhZkNZQXcwV2ZtZ1FqRHpBUWM2S1doeTR1cG5GYUJQeEVscEhHSVRuelE?oc=5", "source_name": "The Business Times", "published_at": "2021-12-14T08:00:00+00:00", "published_display": "14 Dec 2021 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Hyphens Pharma to acquire Novem companies for S$16.3 million", "summary": "", "url": "https://news.google.com/rss/articles/CBMirwFBVV95cUxOc2ZXUDIxMFF3WEVIQ1ZzM2JsYXdvRUZVNVI4UzJJZEJ1QWxEblJydWZ2SUIzYk5aVDVEVmFJUnByMFdPemJQbTFHN2taOUZELXlnSVQxNUpZSlFVN2JOcDB4YTlPYm5ya3dwdDZMSWdBZVFJZFZPNGxkdWxGRlB1RXVnS2JONzZDQUNoaHc4eWNOSUpCekZ5eUwydmRqZmN2bHlyMG9DZGpxbE9SYTRB?oc=5", "source_name": "The Business Times", "published_at": "2021-11-09T08:00:00+00:00", "published_display": "09 Nov 2021 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Hyphens Pharma launches Ceradan Advanced", "summary": "", "url": "https://news.google.com/rss/articles/CBMikwFBVV95cUxQQ3FCaTBpZ05YVzZZVXZLbGthLXViaHUzQTVuWTQtY0dHeFFIaXVaRG9yaGE3aWhRNlhyNHhONXo4Y0JjS3VnME1LbzRCYjBQaGNvbUpkZVdZNHdjVTVOamJxeExsY0ZYZUtteGlaWk9CLWtwZXFyQWktRXdhMnIzbGVteWpBSEotWWRtNWhDSWpTMzQ?oc=5", "source_name": "Market source", "published_at": "2019-07-10T07:00:00+00:00", "published_display": "10 Jul 2019 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Hyphens Pharma rises on Catalist trading debut", "summary": "", "url": "https://news.google.com/rss/articles/CBMimAFBVV95cUxOY25DUUN2dkNmY0daOVBsaHVnLXRucExheGhDTmp2SGxWaXhsUjgtT3d3eFQ5b2QxaTFRNmtBUWs3emVTaHhOaW1fNUJuemMyQlZEeVpJUk9Fc3NDSF90MTdIbXFmOGJTbjRzekRFNjlTTXlLc2kxRmpfWHU5SFVZTk5hRjVRYWJYbVkwU2F4VVJLZHJGQk5kQQ?oc=5", "source_name": "The Straits Times", "published_at": "2018-05-18T07:00:00+00:00", "published_display": "18 May 2018 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Hyphens Pharma International to raise $13.5m in IPO", "summary": "", "url": "https://news.google.com/rss/articles/CBMiiAFBVV95cUxOelU0dHNIejRLanNvbVYzLXhDWjMyN2Y0Uk01ZGs0bDQ3UnBGa3pfNVVmSHhoQWxlbHN5Y0hnYjh3cUNzODI4ZkpGd1FRRDdpaXNldTFIRnB3Nk1LN0tSN3dLeGNIV0h6TnBOMlpZVElKYTJvZ1JnMF9qTWFNaFdfb1NBT255UzdL?oc=5", "source_name": "Singapore Business Review", "published_at": "2018-05-11T07:00:00+00:00", "published_display": "11 May 2018 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "kopi-C with CEO of Hyphens Pharma International: From dispensary to ASEAN's dermatology specialist", "summary": "", "url": "https://news.google.com/rss/articles/CBMiWEFVX3lxTFBySWptZVlGeWdJT3Z0ZXVYOTJ2V3R4M1NXVTRGS3IwdG9rWDNTRW9kcTZfbkxRR1dfMHRVZmVxY2V3Qmo1SzlWMmlMc0VQaHBSSERkRWNiVEQ?oc=5", "source_name": "Beansprout", "published_at": "2026-06-16T07:00:00+00:00", "published_display": "16 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Hyphens Pharma grants Swiss pharma company rights to commercialise Cerapro MED Skin Barrier Cream", "summary": "", "url": "https://news.google.com/rss/articles/CBMiiwFBVV95cUxQQVFlYi1TZjNiYXM1RVNXZVE4bHNKMGlzd240eFBpVE1QaDBxVDR3Y1JCbW50YzI2TkZBNUNoc0h4emk1LUoyckhBMmV6blpnTmQ3bFpSMzJDVHJFU1pXYWJTekEwc2xPeV9GSHRJRkhCT0RBR29mdDFCQVdmRzNTV18tVElsZEZRQkFz?oc=5", "source_name": "Market source", "published_at": "2026-01-04T08:00:00+00:00", "published_display": "04 Jan 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Hyphens Pharma earnings down 66.3% y-o-y for 1HFY2025 to $1.9 mil", "summary": "", "url": "https://news.google.com/rss/articles/CBMihwFBVV95cUxQRnIxbXN0TzBRMHE2WmhQWS1jSzNrVW1MVWYzOW80SnBNSVR2Qno0VFhSdF9FLVdFWVowQWs0T1FrTlBEaS1EZTM1SG1mRXlZUndGUFBqODJVcjFNaTE5VExodjZ0OXItV1FoaEFyUUpSdHRNa0ZXcFBWbUJqWWx2R1M3anA1RWs?oc=5", "source_name": "Market source", "published_at": "2025-08-12T07:00:00+00:00", "published_display": "12 Aug 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Ardence Pharma deal favourable, analysts keep 'buy' on Hyphens Pharma", "summary": "", "url": "https://news.google.com/rss/articles/CBMiugFBVV95cUxQSE9YV094ejlnQXZ5dnc0T3FyVmkzc0JxckZOdkxOLUlNamJvbXducEd5Z19HYzV3c2RJcnBId1FqV0RRZ2tXWW1NNTZMQjR6R2tRVS0tZG9TVWFFRXVTa0tzdDJab2tKcFkwOXVLRGFkTHdYWWVCS3hBWks0aGxLNHpkck5XSnhJdjZ2YVRta3M4Uk1mSms4WFdwa0tZU2NROVFhd1dpY01WdFFoVVNfNW95TU5YcVd1WlE?oc=5", "source_name": "The Edge Singapore", "published_at": "2023-10-23T07:00:00+00:00", "published_display": "23 Oct 2023 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Hyphens Pharma to acquire remaining 58% of shares in Ardence Pharma, making it a wholly-owned subsidiary", "summary": "", "url": "https://news.google.com/rss/articles/CBMiywFBVV95cUxPejB1T1RRdDhWZUxuT3NqbWtQT3BUM0h5WHFfSUQ3WlV6T3ZMQWdpZ1MxWmtxRWcxTUlWQXZ0YkFweWFHQkFIb0t4TjV5amJORmdiYm55NE95azU2THZBVkt5SVZURDkzTHA2Y2VuQklfMFhfME5CR3RvNWtGWFdpaVJ1NWhiOXhyTTV1MDlKWU9na3ZIdFlETlA1SFoxbEtPNzNiaWF4Um9QdWNzQ0NsTkN4UUtMOXk2WHdOYmdCZ3JtNy1GTm5zeF8zWQ?oc=5", "source_name": "The Edge Singapore", "published_at": "2023-10-17T07:00:00+00:00", "published_display": "17 Oct 2023 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "6 Things Investors should know about Hyphens Pharma (SGX: 1J5)", "summary": "", "url": "https://news.google.com/rss/articles/CBMikwFBVV95cUxPSXJtZDBRQ2FnWFRSWHRHUHRDMXhaTEVweWhmRm5BRkVaeDRJWEJhMFFWN2NTdTFhNnU2SXh4cjZQejcySGstWmZDTW90TzRKaUNtZ0VPUVAwQTUxd3U2T1BpVURHSTJlS3UtZk02N3RSRW1tMml5djNFcTB2R29zVTY0TmZJem5tN2NtN0ZPR3RMYmM?oc=5", "source_name": "SmallCapAsia", "published_at": "2022-06-29T07:00:00+00:00", "published_display": "29 Jun 2022 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Hyphens Pharma inks exclusive licensing deal with Favorex to commercialise biosimilar in Singapore, Malaysia, Philippines", "summary": "", "url": "https://news.google.com/rss/articles/CBMi_wFBVV95cUxQd2ZoVEpLUm9hN3BEZUZTekJIWGNxRThjYWxBbmE2ZU44bW40UGc0Ml9FOC1CRVZpVkx1c0tsVDdnU3dPVVk0TGRPeURZLVFuekh6U3lfNk5XSzUwRFJhUTFHSm1BM0dUUXp0NlJMaU5aM0RFNXUzbHl1b0p4T0J6RE1HelBHSHc4bHpQdnpyWVlKdnZVNnNkWFg1UzQzRXIxbTRmUjNYRVoyc0dEVGdHU2dXODNWN0ZCZ3JuX0FBUnRzR3dXNDJNc3VKSzJyWi03T2x6dzZhZkNZQXcwV2ZtZ1FqRHpBUWM2S1doeTR1cG5GYUJQeEVscEhHSVRuelE?oc=5", "source_name": "The Business Times", "published_at": "2021-12-14T08:00:00+00:00", "published_display": "14 Dec 2021 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Hyphens Pharma to acquire Novem companies for S$16.3 million", "summary": "", "url": "https://news.google.com/rss/articles/CBMirwFBVV95cUxOc2ZXUDIxMFF3WEVIQ1ZzM2JsYXdvRUZVNVI4UzJJZEJ1QWxEblJydWZ2SUIzYk5aVDVEVmFJUnByMFdPemJQbTFHN2taOUZELXlnSVQxNUpZSlFVN2JOcDB4YTlPYm5ya3dwdDZMSWdBZVFJZFZPNGxkdWxGRlB1RXVnS2JONzZDQUNoaHc4eWNOSUpCekZ5eUwydmRqZmN2bHlyMG9DZGpxbE9SYTRB?oc=5", "source_name": "The Business Times", "published_at": "2021-11-09T08:00:00+00:00", "published_display": "09 Nov 2021 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Hyphens Pharma launches Ceradan Advanced", "summary": "", "url": "https://news.google.com/rss/articles/CBMikwFBVV95cUxQQ3FCaTBpZ05YVzZZVXZLbGthLXViaHUzQTVuWTQtY0dHeFFIaXVaRG9yaGE3aWhRNlhyNHhONXo4Y0JjS3VnME1LbzRCYjBQaGNvbUpkZVdZNHdjVTVOamJxeExsY0ZYZUtteGlaWk9CLWtwZXFyQWktRXdhMnIzbGVteWpBSEotWWRtNWhDSWpTMzQ?oc=5", "source_name": "Market source", "published_at": "2019-07-10T07:00:00+00:00", "published_display": "10 Jul 2019 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Hyphens Pharma rises on Catalist trading debut", "summary": "", "url": "https://news.google.com/rss/articles/CBMimAFBVV95cUxOY25DUUN2dkNmY0daOVBsaHVnLXRucExheGhDTmp2SGxWaXhsUjgtT3d3eFQ5b2QxaTFRNmtBUWs3emVTaHhOaW1fNUJuemMyQlZEeVpJUk9Fc3NDSF90MTdIbXFmOGJTbjRzekRFNjlTTXlLc2kxRmpfWHU5SFVZTk5hRjVRYWJYbVkwU2F4VVJLZHJGQk5kQQ?oc=5", "source_name": "The Straits Times", "published_at": "2018-05-18T07:00:00+00:00", "published_display": "18 May 2018 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Hyphens Pharma International to raise $13.5m in IPO", "summary": "", "url": "https://news.google.com/rss/articles/CBMiiAFBVV95cUxOelU0dHNIejRLanNvbVYzLXhDWjMyN2Y0Uk01ZGs0bDQ3UnBGa3pfNVVmSHhoQWxlbHN5Y0hnYjh3cUNzODI4ZkpGd1FRRDdpaXNldTFIRnB3Nk1LN0tSN3dLeGNIV0h6TnBOMlpZVElKYTJvZ1JnMF9qTWFNaFdfb1NBT255UzdL?oc=5", "source_name": "Singapore Business Review", "published_at": "2018-05-11T07:00:00+00:00", "published_display": "11 May 2018 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [], "sector": []}, "total_fetched": 71, "total_relevant": 11, "sentiment_summary": {"positive": 2, "negative": 0, "neutral": 9, "score": 53, "total": 11, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 85, "events": [{"event": "general", "label": "Market update", "weight": 4.4, "count": 8}, {"event": "deals", "label": "Deals and strategy", "weight": 1.1, "count": 2}, {"event": "earnings", "label": "Earnings", "weight": 0.55, "count": 1}], "positive_events": 2, "negative_events": 0}, "market_context": {"has_market_context": true, "latest_close": 0.35, "latest_week": "2026-07-10", "one_week_move": 0.0, "four_week_move": 6.1, "twelve_week_move": 12.4, "trend_signal": "1", "trend_label": "Trend active", "trend_tone": "positive", "market_dynamics": 1.201289, "market_dynamics_buy_signal": false, "relative_strength": -8.584888, "fair_value_gap": 24.9, "fair_value_label": "Near fair-value range", "fair_value_tone": "neutral", "expectation_direction": "negative", "expectation_probability": 37.2481, "reaction_label": "Price digesting", "reaction_tone": "neutral", "market_sentence": "+0.0% over one week, +6.1% over four weeks, trend active, and near fair-value range."}, "interpretation": {"label": "Balanced read", "tone": "neutral", "classification": "balanced", "summary": "News tone and price action are not far from neutral.", "confidence": 53, "badges": [], "opportunities": [], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "Market source", "count": 3}, {"label": "The Edge Singapore", "count": 2}, {"label": "The Business Times", "count": 2}, {"label": "Beansprout", "count": 1}, {"label": "SmallCapAsia", "count": 1}, {"label": "The Straits Times", "count": 1}, {"label": "Singapore Business Review", "count": 1}], "tiers": [{"label": "Direct company coverage", "count": 11}, {"label": "Industry context", "count": 0}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 8}, {"label": "Deals and strategy", "count": 2}, {"label": "Earnings", "count": 1}]}, "insights": [{"label": "Weighted tone", "value": "53/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Balanced read", "tone": "neutral", "text": "News tone and price action are not far from neutral."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "85/100 classification confidence."}, {"label": "Company focus", "value": "11", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "0", "tone": "neutral", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend active", "tone": "positive", "text": "+0.0% over one week, +6.1% over four weeks, trend active, and near fair-value range."}, {"label": "Latest direct headline", "value": "Neutral", "tone": "neutral", "text": "kopi-C with CEO of Hyphens Pharma International: From dispensary to ASEAN's dermatology specialist"}], "updated_at": "2026-07-17T18:58:50.958160+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}